⌘K

Login Start Free

Home/Filings/4/0001127602-25-016539

4//SEC Filing

FOSTER JAMES C 4

Accession 0001127602-25-016539

CIK 0001100682other

View on SEC.gov Company Profile

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:46 PM ET

Size

9.8 KB

Accession

0001127602-25-016539

Insider Transaction Report

Form 4

Period: 2025-05-30

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL

DirectorPresident and CEO

Transactions

Award
Common Stock
2025-05-30$135.63/sh+17,253$2,340,024→ 210,685 total

Holdings

Common Stock
(indirect: 2022 GRAT)
4,048
Common Stock
(indirect: By Trust)
230
Common Stock
(indirect: 2024 GRAT)
20,000
Common Stock
(indirect: By Trust)
750
Common Stock
(indirect: By Trust)
2,250
Common Stock
(indirect: By Spouse)
10,000
Common Stock
(indirect: 2025 GRAT)
20,000

Footnotes (2)

[F1]Unvested restricted stock units vest annually on: May 30, 2026; May 30, 2027; May 30, 2028; May 30, 2029.
[F2]Reflects the exempt transfer pursuant to Rule 16a-13 of 9,793 shares from the reporting person's indirect holdings to the reporting person's direct holdings.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CIK 0001100682

Entity typeother

Related Parties

1

filerCIK 0001141722

Filing Metadata

Form type: 4
Filed: Jun 2, 8:00 PM ET
Accepted: Jun 3, 4:46 PM ET
Size: 9.8 KB

View on SEC.gov